Annual Drug Patent Expirations for EQUETRO
Equetro is a drug marketed by Validus Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and two Paragraph IV challenges.
This drug has one patent family member in one country.
The generic ingredient in EQUETRO is carbamazepine. One supplier is listed for this compound. Additional details are available on the carbamazepine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
